PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
This is a prospective study that will assess the impact of MammaPrint on chemotherapy + endocrine versus endocrine alone treatment decisions in patients with an Oncotype Intermediate Score.
The frequency of chemotherapy + endocrine versus endocrine alone decisions in Oncotype DX intermediate score patients will be calculated before and after receiving the MammaPrint result.
Inclusion Criteria:
Exclusion Criteria:
Baltimore, Maryland 21237, United States